Higher solvency than 95% of companies in financial services. The sector median is 51.2%, over 10,288 companies.
Checked score
Outside the general model
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
Model not applicable to financial institutions
The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, an investment fund or an insurer has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
The company is a bank, an investment fund or an insurer. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.
Credit check for an amount and term of your choice
Registered office moved from Fontaine-l'Evêque to Mont-sur-Marchienne
The registered office moved from Rue Demoulin 3, 6142 Fontaine-l'Evêque to rue du Gallois, 2G à 6032 Mont-sur-Marchienne · General meeting of 24-02-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0452353263
3 directors appointed, 2 resignations, 1 reappointmentName hiddenVisible after signing in, Hidden nameVisible after signing in and Name after signing inVisible after signing in appointed · Name hiddenVisible after signing in and Hidden nameVisible after signing in resign · Name after signing inVisible after signing in reappointed as sole director · General meeting of 19-12-2023 · Gazette deed
3 directors reappointedName hiddenVisible after signing in, Hidden nameVisible after signing in and Name after signing inVisible after signing in · General meeting of 30-09-2016 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as VEROVIR PHARMA: financial service activities, except insurance and pension funding (NACE 64190). They are comparable in size and age: total assets between €609,000 and €2m, founded between 1984 and 1996.
According to the KBO register, the main activity is financial service activities, except insurance and pension funding (NACE 64190).
What is the legal form of VEROVIR PHARMA?
VEROVIR PHARMA is a public limited company (NV).
When was VEROVIR PHARMA founded?
VEROVIR PHARMA was founded on 31-03-1994.
Is VEROVIR PHARMA still active?
Yes, VEROVIR PHARMA is an active enterprise in the KBO register.
What is the turnover of VEROVIR PHARMA?
The turnover in financial year 2025 is about €240,000. This figure is estimated from the gross margin of €154,027 and 41 comparable companies (NACE 64). It probably lies between €200,000 and €310,000.Financials
Is VEROVIR PHARMA profitable?
In financial year 2025, VEROVIR PHARMA made a profit of €49,471.
Where can I find the annual accounts of VEROVIR PHARMA?
VEROVIR PHARMA filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of VEROVIR PHARMA due?
VEROVIR PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline